Successful treatment of hemorrhagic syndrome due to an acquired, combined deficiency of factors VII and X in a patient with multiple myeloma and amyloidosis

Eur J Haematol. 1989 Jan;42(1):105-6. doi: 10.1111/j.1600-0609.1989.tb00258.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amyloidosis / complications*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Factor VII Deficiency / complications*
  • Factor X Deficiency / complications*
  • Humans
  • Hypoprothrombinemias / complications*
  • Male
  • Melphalan / administration & dosage
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy
  • Prednisone / administration & dosage
  • Shock, Hemorrhagic / etiology
  • Shock, Hemorrhagic / therapy*
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Cyclophosphamide
  • Melphalan
  • Prednisone

Supplementary concepts

  • VMCP protocol